M-A | Safety and efficacy of abacavir for treating infants, children, and adolescents living with HIV.

Safety and efficacy of abacavir for treating infants, children, and adolescents living with HIV: a systematic review and meta-analysis – The Lancet Child & Adolescent Health

Commentary on Twitter

*New meta-analysis* supports the use of #abacavir as a preferred first-line regimen for infants & children living with #HIV

By @jujesson & colleagueshttps://t.co/WSvp5ZOUf1 pic.twitter.com/qFBo5O3zJC

— The Lancet Child & Adolescent Health (@LancetChildAdol) September 5, 2022